𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Adjuvant chemotherapy in high-risk malignant melanoma

✍ Scribed by Dr. Constantine P. Karakousis; Lawrence J. Emrich


Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
363 KB
Volume
36
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Adjuvant immunotherapy with BCG in stage
✍ M. J. Byrne; G. van Hazel; P. M. Reynolds; W. M. Lemish; C. D. J. Holman πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 223 KB

## Abstract Forty‐one patients were treated with BCG immunotherapy following block dissection of lymph nodes involved with malignant melanoma. A control group of similar patients who received no immunotherapy was drawn from a population consisting of all patients with malignant melanoma diagnosed i

The feasibility of adjuvant interferon Ξ±
✍ Fariba Navid; Wayne L. Furman; Martin Fleming; Bhaskar N. Rao; Sandra Kovach; Ca πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 94 KB

## Abstract ## BACKGROUND It has been shown that induction high‐dose interferon α‐2b (IFN‐α‐2b) followed by maintenance therapy improves recurrence‐free survival in adults with high‐risk, resected melanoma. In this study, the feasibility and toxicity of this regimen were evaluated in newly diagnos